Cargando…

FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma

BACKGROUND: FAS-670 A>G (rs1800682) and FASL-844 C>T (rs763110) polymorphisms have been previously correlated with clinical outcome of non-small cell lung cancer (NSCLC) and breast and bladder cancers. We investigated the influence of these polymorphisms on clinical outcome of malignant pleura...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Hamamsy, Manal, Ghali, Ramy R, Saad, Amr S, Shaheen, Sara M, Salem, Ahmed M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106239/ https://www.ncbi.nlm.nih.gov/pubmed/27853379 http://dx.doi.org/10.2147/OTT.S115631

Ejemplares similares

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC
por: Abed, Sally, et al.
Publicado: (2017)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002)

Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009)

FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders
por: Ozdemirkiran, Fusun Gediz, et al.
Publicado: (2016)

Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis
por: Huang, Donghua, et al.
Publicado: (2018)

Quantitative assessment of the relationship between Fas/FasL genes polymorphisms and head and neck cancer risk
por: Zhang, Dan-Feng, et al.
Publicado: (2018)

Involvement of Fas/FasL pathway in the murine model of atopic dermatitis
por: Bień, Karolina, et al.
Publicado: (2017)

Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation
por: Krzyzowska, Malgorzata, et al.
Publicado: (2021)

Functional Polymorphisms in FAS/FASL System Increase the Risk of Neuroblastoma in Chinese Population
por: Han, Wei, et al.
Publicado: (2013)

Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL
por: Morello, Aurore, et al.
Publicado: (2013)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Prognostic impact of apoptosis marker Fas (CD95) and its ligand (FasL) on bladder cancer in Egypt: study of the effect of schistosomiasis
por: Elmansy, HM, et al.
Publicado: (2012)

Modulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling
por: Yan, Jiabin, et al.
Publicado: (2015)

The signaling pathways by which the Fas/FasL system accelerates oocyte aging
por: Zhu, Jiang, et al.
Publicado: (2016)

Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance
por: Yamada, Akiko, et al.
Publicado: (2017)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans
por: Chatterjee, Koushik, et al.
Publicado: (2009)

FasL Modulates Expression of Mmp2 in Osteoblasts
por: Svandova, Eva, et al.
Publicado: (2018)

Human FasL Gene Is a Target of β-Catenin/T-Cell Factor Pathway and Complex FasL Haplotypes Alter Promoter Functions
por: Wu, Jianming, et al.
Publicado: (2011)

HSV-2 Regulates Monocyte Inflammatory Response via the Fas/FasL Pathway
por: Krzyzowska, Malgorzata, et al.
Publicado: (2013)

Fas/FasL pathway and cytokines in keratinocytes in atopic dermatitis – Manipulation by the electromagnetic field
por: Szymanski, Lukasz, et al.
Publicado: (2018)

Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies
por: Sremec, Josip, et al.
Publicado: (2020)

Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection
por: Krzyzowska, M, et al.
Publicado: (2011)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Association of the Polymorphisms in the Fas/FasL Promoter Regions with Cancer Susceptibility: A Systematic Review and Meta-Analysis of 52 Studies
por: Xu, Yeqiong, et al.
Publicado: (2014)

Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population
por: Zhang, Meijuan, et al.
Publicado: (2016)

Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
por: Flores-Mendoza, Giovanna, et al.
Publicado: (2021)

Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2017)

Functional Polymorphisms of FAS and FASL Gene and Risk of Breast Cancer – Pilot Study of 134 Cases
por: Hashemi, Mohammad, et al.
Publicado: (2013)

FasL (rs763110) gene polymorphism is not associated with susceptibility to rheumatoid arthritis in Croatian population
por: Artuković, Marinko, et al.
Publicado: (2020)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells
por: Carnevale, Gianluca, et al.
Publicado: (2017)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Fas Ligand (FasL) in Association with Tumor-Infiltrating Lymphocytes (TILs) in Early Stage Cervical Cancer
por: Anggraeni, Tricia Dewi, et al.
Publicado: (2020)

FasL Is Required for Osseous Healing in Extraction Sockets in Mice
por: Apaza Alccayhuaman, Karol Alí, et al.
Publicado: (2021)

Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes via activation of p300
por: Otani, Takahito, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pc2t2sao6h311e897foktbbc19